portada COVID-19 and smoking (en Inglés)

Formato

Libro Físico

Autor

Mohamed Abdel-Raheem

Zainab A. Shehab

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

236

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x1.4 cm

Peso

0.35 kg.

ISBN13

9786206150008

Categorías

Medicina: cuestiones generales

COVID-19 and smoking (en Inglés)

Mohamed Abdel-Raheem (Autor) · Zainab A. Shehab (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 26 a 33 días háb.

$ 191.91$ 105.55

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 105.55

Llega entre el 29 Sep y el 13 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "COVID-19 and smoking (en Inglés)"

There is currently insufficient information to confirm any link between nicotine in the prevention or treatment of COVID-19. WHO urges researchers, scientists and the media to be cautious about amplifying unproven claims that tobacco or nicotine could reduce the risk of COVID-19. WHO is constantly evaluating new research, including that which examines the link between tobacco use, nicotine use, and COVID-19. The harms of tobacco use are well-established. Tobacco causes 8 million deaths every year from cardiovascular diseases, lung disorders, cancers, diabetes, and hypertension. Smoking tobacco is also a known risk factor for severe disease and death from many respiratory infections. In the COVID-19 pandemic, questions have been asked about clinical outcomes for smokers, and whether they are equally susceptible to infection, and if nicotine has any biological effect on the SAR-CoV-2 virus (the virus that causes COVID-19). At the time of writing, one clinical trial to test the effects of nicotine has been announced, but no trial registration record was found as of 12 May 2020.